ReviewMini reviews in medicinal chemistry2026
Therapeutic and Pharmacological Flexibility of Cinnamoyl Compounds: Targeting Multiple Signaling Pathways.
Review in Mini reviews in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The extensive array of Natural Products (NPs), ranging from plants to microbes, is wellknown for their varied chemical characteristics and significant biological activity. Historically significant in drug discovery, natural products provide distinctive stereochemistry and complexity generated by diverse biosynthetic pathways. Structural alterations improve effectiveness and diminish adverse effects, driven by advancements in screening, chemistry, and bioinformatics. Natural products have been approved as drug candidates despite the laborious process involved in their isolation and elucidation, demonstrating their relevance. Cinnamaldehyde (CA), derived from Cinnamomum tree bark, exhibits antibacterial, anti-inflammatory, anticancer, antioxidant, neuroprotective, antifungal, and anti-diabetic properties by affecting cellular processes and signaling pathways like PI3K/AKT/mTOR, TGF-β/Smad, NF-κB, TLR4/MyD88/NF-κB, MAPKs, JAK/STAT, and Nrf2/HO-1. Small molecular entities, along with the presence of α,β-unsaturated carbonyl functionality, offer intriguing possibilities within the research framework of synthetic chemistry. Synthetic analogues of CA have been produced; nonetheless, their biological actions remain largely unexamined. The review highlights the pharmacological significance of cinnamoyl functionality, indicating its potential for creating multi-targeted drugs through unexamined structural changes. This review adopts a comprehensive study design, featuring an extensive search of databases like PubMed, Science Direct and Scopus using keywords such as "cinnamoyl compounds," "synthetic derivatives," "therapeutic flexibility," and "pharmacological pathways." Studies were selected based on their relevance to the pharmacological activities of cinnamoyl compounds' synthetic derivatives and their effects on multiple signaling pathways in therapeutic contexts, including experimental data. This article aims to provide theoretical support for the promising development of cinnamoyl compounds as potential candidates for new discoveries and therapeutic advancements.
Indexed as
Identifiers
41140222What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.